"Do I even qualify?" is the question we hear most often, and it usually comes with an apology attached — people assume they're either not heavy enough to be taken seriously or too far along to be helped.
Here's the straightforward version of how eligibility for weight-loss medication actually works in Canada, what the numbers mean, and why the number on its own no longer decides the answer.
The standard entry point for obesity pharmacotherapy — and the criterion used in the major clinical trials — is:
That's the threshold the semaglutide and tirzepatide weight-management trials enrolled on, and it's the benchmark most insurers use when assessing coverage.
To find your BMI: divide your weight in kilograms by your height in metres squared. Someone who is 5'6" (1.68 m) and 190 lb (86 kg) has a BMI of about 30.5. Someone who is 5'10" (1.78 m) and 195 lb (88 kg) is at about 27.8 — below 30, but eligible if a weight-related condition is present.
This is where a lot of people discover they qualify and didn't know it. Conditions commonly considered include:
If you have any of these and a BMI at or above 27, you are likely within the treatment threshold — and worth an assessment even if you'd assumed otherwise.
BMI is a crude tool. It doesn't distinguish muscle from fat, it doesn't say where fat is stored, and it was never designed as an individual diagnostic. A muscular person can register as "obese" without excess adiposity. Someone at a BMI of 26 can carry significant visceral fat with real metabolic consequences.
Canada's 2025 update to the obesity pharmacotherapy guideline addresses this directly: measures of central adiposity, alongside ethnicity-specific BMI cut-offs and adiposity-related health complications, should guide the decision to start medication.
Two things follow from that:
Waist circumference matters. Where fat sits is as informative as how much there is. Visceral fat around the abdomen carries greater metabolic risk than the same weight distributed elsewhere, which is why a waist measurement belongs in the assessment alongside the scale.
BMI thresholds differ by ethnicity. Metabolic risk begins at lower BMI values in several populations — notably South Asian, Chinese, and other East and Southeast Asian groups. Applying a single 30 cut-off to everyone systematically under-identifies risk in those populations. If you've been told you're "fine" on the basis of a standard BMI chart, that may not be the right chart.
The practical upshot: eligibility is a clinical judgment informed by several measurements, not a single number you either clear or don't.
Health Canada has approved six medications for long-term obesity management:
The GLP-1 medications get the attention, and we compare the two leading options in detail in our post on semaglutide vs tirzepatide. But they aren't the only route, and they aren't right for everyone. The correct medication depends on your health conditions, your other medications, tolerability, and cost — not on which one is in the news.
Medication is also one part of a program, not the whole of it. Canadian guidance is consistent that pharmacotherapy works alongside health behaviour change, not instead of it, and for some people a structured meal-replacement approach like OPTIFAST® is the better starting point.
Eligibility runs in both directions, and there are situations where these medications aren't appropriate or need to wait:
None of these is automatically the end of the conversation. Some rule out a specific medication rather than treatment altogether; others mean sequencing care differently. That's what the assessment is for.
A first consultation at our clinic takes about 45 minutes to an hour and covers:
You are not committing to a prescription by booking an assessment. Some people leave with a medication plan, some with a behaviour and nutrition plan, some with a referral. All three are real outcomes.
Weight-management medications are generally not covered by Alberta Health. Many private and employer plans do cover them, often with prior authorization requiring documented BMI and a weight-related condition — which is one practical reason the assessment paperwork matters. We break down what treatment actually costs in our post on weight-loss medication costs in Calgary.
Check your plan for "weight management" or "anti-obesity" medication before your appointment if you can. If you don't have coverage, say so early — it genuinely changes which options we recommend, and we'd rather build a plan you can sustain than one you abandon in month three.
What BMI do you need for weight-loss medication?
Generally a BMI of 30 or higher, or 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, sleep apnea, or fatty liver disease. Canada's 2025 guideline adds that waist circumference, ethnicity-specific BMI cut-offs, and your adiposity-related conditions should also inform the decision.
Can I get weight-loss medication with a BMI under 27?
Usually not for obesity pharmacotherapy, and insurers rarely cover it. An assessment is still worthwhile — waist circumference and ethnicity-specific thresholds sometimes change the picture, and there are non-medication approaches that may fit.
Do I need a doctor's referral?
No. You can book directly with our pharmacist-led team in NW Calgary. We work with your family physician where that's helpful.
Does BMI work differently for different ethnicities?
Yes. Metabolic risk starts at lower BMI values in several populations, including South Asian and East and Southeast Asian groups, and Canadian guidance recommends using ethnicity-specific cut-offs rather than one universal threshold.
Will my insurance cover it?
Alberta Health generally doesn't. Many private plans do, usually with prior authorization requiring documented BMI and a weight-related condition. Check your plan for "weight management" coverage, and bring what you find to your appointment.
What if I don't qualify for medication?
Medication is one tool among several. Structured nutrition, behaviour change, and medically supervised meal replacement are all real options, and an assessment will tell you which ones make sense for you.
Not sure where you land? Book an assessment with our pharmacist-led team and find out properly, rather than guessing from a BMI chart.
*Medically reviewed by Wessam Sakr, BScPharm. This article is general information, not medical advice for your specific situation. Talk to a healthcare professional about what's right for you.*
Ready to talk to a professional? Book a consultation with our pharmacist-led team to find the right medically supervised approach for you.